U.S. Insurance Stock News

BeOne Medicines Ltd. recently reported second quarter 2025 earnings, showing revenue of US$1.32 billion and net income of US$94.32 million, marking a reversal from net losses in the previous year. The company also raised its full-year 2025 revenue guidance and now expects positive GAAP operating income, highlighting improved operational performance and momentum in its oncology business. We'll explore how BeOne's move to profitability and higher revenue guidance affect its investment...

AbCellera Biologics reported its second quarter and six-month earnings, showing quarterly revenue of US$17.08 million, more than doubling from a year ago, while six-month revenue reached US$21.32 million. Despite ongoing net losses, the strong revenue growth compared to the prior year signals business progress and could shift perceptions on the company’s operational momentum. We’ll examine how this recent revenue surge may affect the company’s outlook and the broader investment...

Oscar Health, Inc. and Hy-Vee, Inc. recently unveiled a new employer health insurance plan combining Oscar’s technology platform with Hy-Vee’s retail and pharmacy network, offering concierge care and $0 cost services for employees through the “Hy-Vee Health with Oscar” program. This collaboration introduces a comprehensive suite of health and shopping benefits, aiming to simplify healthcare delivery for employees while helping employers manage costs. We’ll explore how Oscar’s entry...

Liberty Broadband reported strong earnings for the second quarter ended June 30, 2025, with sales rising to US$261 million and net income increasing to US$383 million from the previous year. Despite not repurchasing any shares in the latest quarter, the company has completed a massive buyback program totaling nearly 34.2% of its outstanding shares since 2016, amounting to over US$8.1 billion. We’ll examine how Liberty Broadband’s significant year-over-year net income growth updates its...

Earlier this month, Oddity Tech Ltd. reported second quarter sales of US$241.14 million and net income of US$49.29 million, also raising its full-year 2025 net revenue guidance to a new range of US$799 million to US$804 million. This upward revision to revenue targets following robust quarterly results highlights the company’s confidence in its operating momentum and future demand outlook. We’ll explore how Oddity Tech’s strengthened full-year guidance, reflecting accelerating business...

Globus Medical reported strong second-quarter 2025 results, with sales of US$745.34 million and net income of US$202.85 million, along with reaffirmed full-year revenue guidance of US$2.80 billion to US$2.90 billion. The company completed a share buyback of 411,000 shares for US$24.99 million, signaling ongoing confidence in its capital allocation strategy. We’ll now explore how Globus Medical’s robust earnings growth and reaffirmed guidance influence its broader investment narrative. We've...

Ascendis Pharma released its second quarter and half-year 2025 financial results, reporting sales of €158.05 million and €259 million, respectively, with both periods showing sharply reduced net losses compared to the previous year. This marked improvement in revenue and narrowing of net loss highlights the company's progress toward greater financial stability and operational efficiency as of June 30, 2025. We'll explore how the substantial year-over-year revenue growth and reduced net loss...

In recent days, Trump Media & Technology Group Corp. announced a series of product and content expansion moves, including adding GB News to Truth+, launching an on-demand slate from Great American Media, and beginning public Beta testing of an AI-powered search feature for Truth Social. These developments mark the company’s continued push to broaden its global reach and diversify its digital streaming and engagement offerings through technology-driven features. We'll explore how the launch...

On August 11, 2025, Fluence Energy reaffirmed its fiscal year 2025 revenue guidance at a range of US$2.6 billion to US$2.8 billion, but now expects to reach the lower end of the range due to slower production ramp-up at its new U.S. manufacturing facilities, shifting some anticipated revenue to fiscal year 2026. This delay in production comes as the company maintains its annual recurring revenue guidance and expects the facilities to achieve target capacity by year-end, bolstering its...

NANO Nuclear Energy Inc. recently announced earnings results for the quarter and nine months ended June 30, 2025, reporting a third-quarter net loss of US$7.59 million and a year-to-date net loss of US$32.02 million, both higher than the prior year. Losses per share also widened from the previous year, suggesting increased operational costs or investments contributing to the deeper losses. We'll examine how the larger net loss shapes NANO Nuclear Energy's investment narrative around future...

CF Industries Holdings released its second-quarter 2025 results, reporting US$1.89 billion in sales, steady ammonia production, and updates on share repurchase activity completed under its ongoing buyback program. Notably, management issued full-year guidance projecting gross ammonia output to reach approximately 10 million tons, highlighting continued focus on production scale and operational efficiency. To understand the potential impact on CF Industries Holdings' investment outlook, we'll...

Harmony Biosciences Holdings recently reported second-quarter 2025 earnings, revealing net income of US$39.78 million versus US$11.59 million a year earlier and reaffirmed its full-year 2025 revenue guidance of US$820 million to US$860 million. This sharp improvement in earnings and maintained revenue outlook highlights the company’s operational momentum and management’s confidence in its ongoing business performance. With Harmony Biosciences delivering much higher profits and upholding its...

Earlier this month, Sunrun announced a rapid migration of its operations to Oracle Warehouse Management Cloud and reported strong second-quarter earnings with net income of US$279.77 million, more than doubling year over year. An independent study released by The Brattle Group also revealed that Sunrun's fleet of over 100,000 residential batteries supplied the majority of distributed energy during a major California grid event, underscoring the company's growing influence in the home energy...

Bentley Systems recently completed a share repurchase of 499,143 shares for US$20 million and announced its second quarter 2025 financial results, reporting US$364.11 million in revenue and US$70.48 million in net income. An interesting detail is that despite year-over-year revenue growth, net income for the second quarter was steady, highlighting the company’s emphasis on shareholder returns through continued buyback activity. We'll examine how the blend of rising revenue and steady...

Grindr Inc. recently announced its second quarter 2025 earnings results, reporting sales of US$104.22 million and a net income of US$16.64 million, marking a shift from a net loss for the same period last year. This turnaround to profitability, alongside strong year-over-year revenue growth, reflects the company’s improved operational performance and shifting financial trajectory. Now, we’ll explore how Grindr’s return to profitability could influence its investment narrative and future...

Core Scientific reported its second quarter 2025 earnings on August 8, showing revenue of US$78.63 million compared to US$141.1 million a year earlier, with a net loss of US$936.8 million and basic loss per share from continuing operations of US$0.04. Despite continued year-over-year declines in revenue and net losses, major Wall Street analysts recently upgraded or reaffirmed positive ratings for the company after the earnings report. We’ll examine how improved analyst sentiment, following...

Earlier this month, Dynavax Technologies Corporation raised its full-year 2025 revenue guidance for HEPLISAV-B to a range of US$315 million to US$325 million and posted quarterly results showing second-quarter revenue climbed to US$95.44 million, with net income reaching US$18.72 million. The guidance increase reflects strong performance in the first half, while the earnings report highlights significant year-over-year growth in both revenue and profit margins for the company. To understand...

Kenvue recently reported its second-quarter 2025 earnings, with net income rising to US$420 million from US$58 million a year earlier, while sales declined to US$3,839 million from US$4,000 million; the company also revised its full-year 2025 guidance, now expecting net and organic sales to be down low-single-digits. Alongside the financial update, Kenvue announced the appointment of a new Chief Technology & Data Officer and completed a significant share buyback, indicating both leadership...

Earlier this month, V2X, Inc. filed for a follow-on equity offering of 2,000,000 shares of common stock shortly after reporting a return to profitability in its second-quarter results and reaffirming its full-year revenue guidance. This sequence of events highlights how the company is taking advantage of renewed financial momentum to strengthen its balance sheet through equity financing. We'll explore how V2X’s follow-on equity offering, coming right after its profitability turnaround, may...

In the past week, Claritev Corporation reported second-quarter results showing higher sales at US$241.57 million and a sharply reduced net loss of US$62.64 million, while updating its full-year 2025 revenue guidance to between flat and 2% growth from 2024 levels. The company’s US$400 million universal shelf registration, covering a range of securities, adds financial flexibility to support potential future initiatives and growth plans. We will explore how Claritev’s improving financial...

Vera Therapeutics recently reported a second quarter net loss of US$76.53 million, significantly higher than a year ago, and announced a US$200 million follow-on equity offering of Class A common stock. The concurrent disclosure of increased quarterly losses and a major capital raise highlights potential funding needs and ongoing operational pressures facing the company. We’ll examine how Vera Therapeutics’ expanded capital raise shapes its investment narrative amid growing financial...

The board of Energizer Holdings, Inc. ( NYSE:ENR ) has announced that it will pay a dividend of $0.30 per share on the...

Precigen ( NASDAQ:PGEN ) Second Quarter 2025 Results Key Financial Results Net loss: US$26.6m (loss narrowed by 55...

NasdaqCM:OPXS 1 Year Share Price vs Fair Value Explore Optex Systems Holdings's Fair Values from the Community and...